Research Interests
Genetic basis of therapeutic resistance in glioblastoma and identification of therapeutic targets that reverses resistance to standard of care therapies.
Genetic basis of therapeutic resistance in glioblastoma and identification of therapeutic targets that reverses resistance to standard of care therapies.